Global Lou Gehrigs Disease Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 156755
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.

Scope of the Report:

This report focuses on the Lou Gehrigs Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Lou Gehrigs Disease is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

AB Science

Avicena Group

Biogen

BrainStorm Therapeutics

Covis Pharmaceutical Inc.

Cytokinetics Inc.

Eisai Co. Ltd.

GlaxoSmithKline plc.

Ionis Pharmaceuticals, Inc.

Mitsubishi Tanabe Pharma Corp.

Neuralstem Inc.

Neuraltus Pharmaceuticals Inc.

Newron Pharmaceuticals S.p.A.

Nutra Pharma Corp.

Pharnext SAS

Q-Therapeutics Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Riluzole

Edaravone (Radicava)

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail & Online Pharmacie

There are 15 Chapters to deeply display the global Lou Gehrigs Disease market.

Chapter 1, to describe Lou Gehrigs Disease Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Lou Gehrigs Disease, with sales, revenue, and price of Lou Gehrigs Disease, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Lou Gehrigs Disease, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Lou Gehrigs Disease market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Lou Gehrigs Disease sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Lou Gehrigs Disease Introduction

1.2 Market Analysis by Type

1.2.1 Riluzole

1.2.2 Edaravone (Radicava)

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacies

1.3.2 Retail & Online Pharmacie

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AB Science

2.1.1 Business Overview

2.1.2 Lou Gehrigs Disease Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AB Science Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Avicena Group

2.2.1 Business Overview

2.2.2 Lou Gehrigs Disease Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Avicena Group Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biogen

2.3.1 Business Overview

2.3.2 Lou Gehrigs Disease Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biogen Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 BrainStorm Therapeutics

2.4.1 Business Overview

2.4.2 Lou Gehrigs Disease Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Covis Pharmaceutical Inc.

2.5.1 Business Overview

2.5.2 Lou Gehrigs Disease Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Cytokinetics Inc.

2.6.1 Business Overview

2.6.2 Lou Gehrigs Disease Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Cytokinetics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Eisai Co. Ltd.

2.7.1 Business Overview

2.7.2 Lou Gehrigs Disease Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 GlaxoSmithKline plc.

2.8.1 Business Overview

2.8.2 Lou Gehrigs Disease Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Ionis Pharmaceuticals, Inc.

2.9.1 Business Overview

2.9.2 Lou Gehrigs Disease Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Mitsubishi Tanabe Pharma Corp.

2.10.1 Business Overview

2.10.2 Lou Gehrigs Disease Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Neuralstem Inc.

2.11.1 Business Overview

2.11.2 Lou Gehrigs Disease Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Neuralstem Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Neuraltus Pharmaceuticals Inc.

2.12.1 Business Overview

2.12.2 Lou Gehrigs Disease Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Newron Pharmaceuticals S.p.A.

2.13.1 Business Overview

2.13.2 Lou Gehrigs Disease Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Nutra Pharma Corp.

2.14.1 Business Overview

2.14.2 Lou Gehrigs Disease Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Nutra Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Pharnext SAS

2.15.1 Business Overview

2.15.2 Lou Gehrigs Disease Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Pharnext SAS Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Q-Therapeutics Inc.

2.16.1 Business Overview

2.16.2 Lou Gehrigs Disease Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Q-Therapeutics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Lou Gehrigs Disease Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Lou Gehrigs Disease Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Lou Gehrigs Disease Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Lou Gehrigs Disease Manufacturer Market Share in 2017

3.3.2 Top 6 Lou Gehrigs Disease Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Lou Gehrigs Disease Market Analysis by Regions

4.1 Global Lou Gehrigs Disease Sales, Revenue and Market Share by Regions

4.1.1 Global Lou Gehrigs Disease Sales and Market Share by Regions (2013-2018)

4.1.2 Global Lou Gehrigs Disease Revenue and Market Share by Regions (2013-2018)

4.2 North America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

4.3 Europe Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

4.5 South America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

5 North America Lou Gehrigs Disease by Countries

5.1 North America Lou Gehrigs Disease Sales, Revenue and Market Share by Countries

5.1.1 North America Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)

5.1.2 North America Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)

5.2 United States Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

5.3 Canada Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

5.4 Mexico Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

6 Europe Lou Gehrigs Disease by Countries

6.1 Europe Lou Gehrigs Disease Sales, Revenue and Market Share by Countries

6.1.1 Europe Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)

6.2 Germany Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

6.3 UK Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

6.4 France Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

6.5 Russia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

6.6 Italy Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

7 Asia-Pacific Lou Gehrigs Disease by Countries

7.1 Asia-Pacific Lou Gehrigs Disease Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)

7.2 China Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

7.3 Japan Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

7.4 Korea Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

7.5 India Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

8 South America Lou Gehrigs Disease by Countries

8.1 South America Lou Gehrigs Disease Sales, Revenue and Market Share by Countries

8.1.1 South America Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)

8.1.2 South America Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

8.3 Argentina Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

8.4 Colombia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

9 Middle East and Africa Lou Gehrigs Disease by Countries

9.1 Middle East and Africa Lou Gehrigs Disease Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

9.3 UAE Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

9.4 Egypt Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

9.5 Nigeria Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

9.6 South Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)

10 Global Lou Gehrigs Disease Market Segment by Type

10.1 Global Lou Gehrigs Disease Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Lou Gehrigs Disease Sales and Market Share by Type (2013-2018)

10.1.2 Global Lou Gehrigs Disease Revenue and Market Share by Type (2013-2018)

10.2 Riluzole Sales Growth and Price

10.2.1 Global Riluzole Sales Growth (2013-2018)

10.2.2 Global Riluzole Price (2013-2018)

10.3 Edaravone (Radicava) Sales Growth and Price

10.3.1 Global Edaravone (Radicava) Sales Growth (2013-2018)

10.3.2 Global Edaravone (Radicava) Price (2013-2018)

11 Global Lou Gehrigs Disease Market Segment by Application

11.1 Global Lou Gehrigs Disease Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacies Sales Growth (2013-2018)

11.3 Retail & Online Pharmacie Sales Growth (2013-2018)

12 Lou Gehrigs Disease Market Forecast (2018-2023)

12.1 Global Lou Gehrigs Disease Sales, Revenue and Growth Rate (2018-2023)

12.2 Lou Gehrigs Disease Market Forecast by Regions (2018-2023)

12.2.1 North America Lou Gehrigs Disease Market Forecast (2018-2023)

12.2.2 Europe Lou Gehrigs Disease Market Forecast (2018-2023)

12.2.3 Asia-Pacific Lou Gehrigs Disease Market Forecast (2018-2023)

12.2.4 South America Lou Gehrigs Disease Market Forecast (2018-2023)

12.2.5 Middle East and Africa Lou Gehrigs Disease Market Forecast (2018-2023)

12.3 Lou Gehrigs Disease Market Forecast by Type (2018-2023)

12.3.1 Global Lou Gehrigs Disease Sales Forecast by Type (2018-2023)

12.3.2 Global Lou Gehrigs Disease Market Share Forecast by Type (2018-2023)

12.4 Lou Gehrigs Disease Market Forecast by Application (2018-2023)

12.4.1 Global Lou Gehrigs Disease Sales Forecast by Application (2018-2023)

12.4.2 Global Lou Gehrigs Disease Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Lou Gehrigs Disease Picture

Table Product Specifications of Lou Gehrigs Disease

Figure Global Sales Market Share of Lou Gehrigs Disease by Types in 2017

Please fill the form below, to recieve the report sample


+1